首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinica e investigacion en arteriosclerosis

缩写:

ISSN:0214-9168

e-ISSN:1578-1879

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引627
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
José Luis Díaz-Díaz,M Eugenia Ameneiros,Rosa Argüeso Armesto et al. José Luis Díaz-Díaz et al.
Objectives: GALIPEMIAS is a study designed to determine the prevalence of familial dyslipidemias in the adult population of Galicia, evaluate the degree of lipid control according to the criteria of current clinical guide...
Santiago Redondo Santiago Redondo
In the last decade, the coming of next-generation sequencing and its application to large human populations is breaking the barrier between inflammation and cancer. Indeed, acquired mutations in key genes that regulate hematopoiesis and thu...
Francisco Gomez-Delgado,Manuel Raya-Cruz,Juan L Romero-Cabrera et al. Francisco Gomez-Delgado et al.
Environmental pollution is a key factor in cardiovascular disease (CVD) development. Several evidences support its impact at the pathophysiology of arteriosclerosis, highlighting the role of the "exposome", a concept that encompasses all en...
Irving Mauricio Lecona Licona,José María Rodríguez Lelis,Joaquín Pérez Ortega et al. Irving Mauricio Lecona Licona et al.
Introduction: Ischemic diseases are the second leading cause of death in Mexico and account for over 30% of deaths worldwide. Atherosclerosis, in particular, obstructs arteries and impairs blood circulation, contributing ...
Ángel Arturo López-González,José Ignacio Ramírez-Manent,Emilio Martínez-Almoyna Rifá et al. Ángel Arturo López-González et al.
Introduction: Atherosclerosis is a multifactorial process underlying major cardiovascular diseases (CVDs). Among the associated risk factors, lipoprotein ratios have been identified as key indicators of atherogenic risk. ...
Rosa Fernández-Olmo,Alberto Cordero,Armando Oterino et al. Rosa Fernández-Olmo et al.
In recent years we have been experiencing an advance in lipid-lowering therapies, with the appearance of new drugs that act on the different metabolic pathways, reducing both the levels of cholesterol associated with low-density lipoprotein...
Jiali Xu,Nana Deng,Zhouyue Zhang et al. Jiali Xu et al.
Objective: Post-acute pancreatitis diabetes mellitus (PPDM-A) is a type of diabetes linked to pancreatic exocrine dysfunction, which increases the risk of pancreatic cancer and mortality. Hyperlipidemia, or high blood lip...
Teresa Arrobas Velilla,Salomon Martin Perez,Carla Fernández Prendes et al. Teresa Arrobas Velilla et al.
Introduction: Lipoprotein a is considered an independent factor of atherosclerotic cardiovascular disease with high prevalence, but the availability of real and updated data in Spain as well as determination protocols are...
Juan Cosín Sales,Carlos Escobar Cervantes,José Javier Gómez-Barrado et al. Juan Cosín Sales et al.
Aims: A high number of patients do not achieve the therapeutic goals set by clinical practice guidelines, despite the therapeutic alternatives that currently exist in lipid-lowering treatment (LLT). This study aimed to es...